In recent years, there has been increasing interest in the identification and validation of brain biomarkers in clinical routine, and the utility of blood S100B as a brain injury marker has been documented in multiple contexts such as with circulatory arrest, stroke and TBI [63,64,65]. This evidence concerns the gene S100B and cardiac arrest.